Efinaconazole 10% Nail Solution

  title={Efinaconazole 10% Nail Solution},
  author={A. Gupta and M. Paquet},
  journal={Journal of Cutaneous Medicine and Surgery},
  pages={151 - 155}
  • A. Gupta, M. Paquet
  • Published 2014
  • Medicine
  • Journal of Cutaneous Medicine and Surgery
  • Background: Topical therapies for onychomycosis are associated with less adverse events than systemic therapies, but poor nail penetration limits their efficacy. Consequently, an efinaconazole 10% nail solution was developed. Objective: To review the evidence supporting the usefulness of efinaconazole monotherapy in onychomycosis management. Methods: PubMed and clinicaltrials.gov databases and abstracts from the 2013 annual meeting of the American Academy of Dermatology were searched in April… CONTINUE READING
    5 Citations

    Tables and Topics from this paper.

    Tazarotene as alternative topical treatment for onychomycosis
    • 9
    • PDF
    [Affinity of Luliconazole for Human Nail Derived Keratin].
    • 1
    Regulatory Requirements and Innovation: A Comparison of the Dermatologic Antifungal Drug Product Markets in Brazil and United States


    Efinaconazole 10% solution in the treatment of toenail onychomycosis: Two phase III multicenter, randomized, double-blind studies.
    • 162
    • PDF
    Tazarotene as alternative topical treatment for onychomycosis
    • 9
    • PDF
    An upcoming drug for onychomycosis: Tavaborole
    • 22
    Onychomycosis in Iran: epidemiology, causative agents and clinical features.
    • 49
    • PDF
    The prevalence of fungi in fingernail onychomycosis.
    • 30
    Onychomycosis in São Paulo, Brazil
    • 57
    • PDF
    Candidal onychomycosis: A Mini-Review
    • 64
    The use of topical therapies to treat onychomycosis.
    • 51